New test set to target growth hormone misuse:
This article was originally published in Clinica
Researchers have developed an immunoassay that could indicate whether an athlete has misused recombinant human growth hormone (r-hGH). "Doping" has until now been considered undetectable because once injected, r-hGH is identical to a form of naturally occurring pituitary-derived human growth hormone, said the research team, which was led by Dr Christian Strasburger of Innenstadt University Hospital, Munich, Germany. In an assessment of 165 serum samples, the test correctly ruled out everyone who had not used r-hGH, according to a letter published in The Lancet (March 13).